The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 10, 2021

Filed:

Feb. 17, 2021
Applicant:

Springworks Therapeutics Inc., Stamford, CT (US);

Inventors:

Kristin Patterson, Stamford, CT (US);

Jiping Liu, Stamford, CT (US);

Ricky Wayne Couch, Durham, NC (US);

Peter Gregory Varlashkin, Durham, NC (US);

Mai Li, Greenville, SC (US);

Yonghong Gan, Simpsonville, SC (US);

Assignee:

SpringWorks Therapeutics, Inc., Stamford, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/16 (2006.01); C07C 231/00 (2006.01); A61P 35/00 (2006.01); C07C 259/10 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
C07C 259/10 (2013.01); A61K 9/0095 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present disclosure relates to a) crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide; b) pharmaceutical compositions comprising one or more crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide, and, optionally, one or more pharmaceutically acceptable carriers; c) methods of treating a tumor a cancer, or a Rasopathy disorder by administering one or more crystalline forms of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide to a subject in need thereof, and methods of producing essentially pure Form IV of N—((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide.


Find Patent Forward Citations

Loading…